Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of Polymorphisms in CYP2E1 Gene and Association Analysis among Chronic HBV Patients

  • Chun, Ji-Yong (Department of Life Science, Sogang University) ;
  • Park, Byung-Lae (Department of Genetic Epidemiology, SNP Genetics, Inc.) ;
  • Cheong, Hyun-Sub (Department of Genetic Epidemiology, SNP Genetics, Inc.) ;
  • Kim, Jason-Y. (Department of Life Science, Sogang University) ;
  • Park, Tae-Joon (Department of Life Science, Sogang University) ;
  • Lee, Jin-Sol (Department of Life Science, Sogang University) ;
  • Lee, Hyo-Suk (Department of Internal Medicine and Liver Research Institute, Seoul National University) ;
  • Kim, Yoon-Jun (Department of Internal Medicine and Liver Research Institute, Seoul National University) ;
  • Shin, Hyoung-Doo (Department of Life Science, Sogang University)
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Cytochrome P450 2E1 (CYP2E1) is a member of the cytochrome P450 superfamily, and it is a key enzyme responsible for the metabolic activation of many smallmolecular-weight compounds such as alcohol, which is classified as a human carcinogen. In this study, we identified 19 single nucleotide polymorphisms (SNPs) in CYP2E1 in Korean population. In these SNPs, we examined possible genetic association of CYP2E1 polymorphisms with HBV clearance and the risk of hepatocellular carcinoma (HCC). Five common polymorphic sites were selected, CYP2E1 polymorphisms at rs381-3867, rs3813870, rs2070673, rs2515641 and rs2480257, considering their allele frequencies, haplotype-tagging status and LDs for genotyping in larger-scale subjects (n=1,092). Statistical analysis demonstrated that CYP2E1 polymorphisms and haplotypes show no significant association with HBV clearance, HCC occurrence and onset age of HCC (p>0.05). Previous studies, however, have shown contradictory findings on associations of CYP2E1 polymorphisms with CYP2E1 activities and HCC risk. Comparing the contrasting results of previous researches suggest that CYP2E1 polymorphism is associated with CYP2E1 activity induced by ethanol, but is not directly associated with HCC risk. CYP2E1 variation/haploype information identified in this study will provide valuable information for future studies on CYP2E1.

Keywords

References

  1. Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Altieri, A., and Cogliano, V. (2007). Carcinogenicity of alcoholic beverages. Lancet Oncol . 8, 292-293 https://doi.org/10.1016/S1470-2045(07)70099-2
  2. Bae, S.H., Yoon, S.K., Jang, J.W., Kim, C.W., Nam, S.W., Choi, J.Y., Kim, B.S., Park, Y.M., Suzuki, S., Sugauchi, F., and Mizokami, M. (2005). Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J. Korean Med. Sci . 20, 816-820 https://doi.org/10.3346/jkms.2005.20.5.816
  3. Barrett, J.C., Fry, B., Maller, J., and Daly, M.J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 https://doi.org/10.1093/bioinformatics/bth457
  4. Bosch, F.X., Ribes, J., Cl\acute{e}ries, R., and Dí\acute{a}z, M. (2005). Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9, 191-211 https://doi.org/10.1016/j.cld.2004.12.009
  5. Bruix, J., Sherman, M., Llovet, J.M., Beaugrand, M., Lencioni, R., Burroughs, A.K., Christensen, E., Pagliaro, L., Colombo, M., and Rodes, J. (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol . 35, 421-430 https://doi.org/10.1016/S0168-8278(01)00130-1
  6. Carriere, V., Berthou, F., Baird, S., Belloc, C., Beaune, P., and de Waziers, I. (1996). Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics 6, 203-211 https://doi.org/10.1097/00008571-199606000-00002
  7. Cruz, A.C., Frentzen, B.H., and Behnke, M. (1987). Hepatitis B: a case for prenatal screening of all patients. Am. J. Obstet. Gynecol . 156, 1180-1183 https://doi.org/10.1016/0002-9378(87)90137-2
  8. Dilger, K., Metzler, J., Bode, J.C., and Klotz, U. (1997). CYP2E1 activity in patients with alcoholic liver disease. J. Hepatol . 27, 1009-1014 https://doi.org/10.1016/S0168-8278(97)80144-4
  9. El-Serag, H.B., and Mason, A.C. (2000). Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med. 160, 3227-3230 https://doi.org/10.1001/archinte.160.21.3227
  10. Gebhardt, A.C., Lucas, D., Menez, J.F., and Seitz, H.K. (1997). Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 26, 957-961 https://doi.org/10.1002/hep.510260423
  11. Girre, C., Lucas, D., Hispard, E., Menez, C., Dally, S., and Menez, J.F. (1994). Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47, 1503-1508 https://doi.org/10.1016/0006-2952(94)90524-X
  12. Grove, J., Brown, A.S., Daly, A.K., Bassendine, M.F., James, O.F., and Day, C.P. (1998). The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 8, 335-342 https://doi.org/10.1097/00008571-199808000-00007
  13. Guengerich, F.P., Kim, D.H., and Iwasaki, M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168-179 https://doi.org/10.1021/tx00020a008
  14. Hayashi, S., Watanabe, J., and Kawajiri, K. (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem . 110, 559-565
  15. Hedrick, P., and Kumar, S. (2001). Mutation and linkage disequilibrium in human mtDNA. Eur. J. Hum. Genet . 9, 969-972 https://doi.org/10.1038/sj.ejhg.5200735
  16. Inoue, K., Yamazaki, H., and Shimada, T. (2000). Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene. Arch. Toxicol. 74, 372-378 https://doi.org/10.1007/s002040000151
  17. Kharasch, E.D., Thummel, K.E., Mhyre, J., and Lillibridge, J.H. (1993). Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1. Clin. Pharmacol. Ther . 53, 643-650 https://doi.org/10.1038/clpt.1993.85
  18. Koop, D.R. (1992). Oxidative and reductive metabolism by cytochrome P450 2E1. Faseb. J . 6, 724-730
  19. Ladero, J.M., Agundez, J.A., Rodriguez-Lescure, A., Diaz Rubio, M., and Benitez, J. (1996). RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut 39, 330-333 https://doi.org/10.1136/gut.39.2.330
  20. Lavanchy, D. (2005). Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 34, S1-3
  21. Leclercq, I., Desager, J.P., and Horsmans, Y. (1998). Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin. Pharmacol. Ther . 64, 144-149 https://doi.org/10.1016/S0009-9236(98)90147-3
  22. Lee, M.S., Kim, D.H., Kim, H., Lee, H.S., Kim, C.Y., Park, T.S., Yoo, K.Y., Park, B.J., and Ahn, Y.O. (1998). Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: a cohort study in Korea. Int. J. Epidemiol . 27, 316-319 https://doi.org/10.1093/ije/27.2.316
  23. Livak, K.J. (1999). Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet. Anal . 14, 143-149 https://doi.org/10.1016/S1050-3862(98)00019-9
  24. Lucas, D., Menez, C., Girre, C., Berthou, F., Bodenez, P., Joannet, I., Hispard, E., Bardou, L.G., and Menez, J.F. (1995). Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5, 298-304 https://doi.org/10.1097/00008571-199510000-00005
  25. Marchand, L.L., Wilkinson, G.R., and Wilkens, L.R. (1999). Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol. Biomarkers Prev . 8, 495-500
  26. McCarver, D.G., Byun, R., Hines, R.N., Hichme, M., and Wegenek, W. (1998). A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol. Appl. Pharmacol . 152, 276-281 https://doi.org/10.1006/taap.1998.8532
  27. Menashe, I., Rosenberg, P.S., and Chen, B.E. (2008). PGA: power calculator for case-control genetic association analyses. BMC Genet 9, 36 https://doi.org/10.1186/1471-2156-9-36
  28. Morgan, T.R., Mandayam, S., and Jamal, M.M. (2004). Alcohol and hepatocellular carcinoma. Gastroenterology 127, S87-96 https://doi.org/10.1053/j.gastro.2004.09.020
  29. O'Shea, D., Davis, S.N., Kim, R.B., and Wilkinson, G.R. (1994). Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin. Pharmacol. Ther. 56: 359-367 https://doi.org/10.1038/clpt.1994.150
  30. Odgerel, Z., Nho, K.B., Moon, J.Y., Kee, S.H., Park, K.S., Song, K.J., Baek, L.J., Yeon, J.E., Byun, K.S., Lee, C.H., and Song, J.W. (2003). Complete genome sequence and phylogenetic analysis of hepatitis B virus (HBV) isolates from patients with chronic HBV infection in Korea. J. Med. Virol . 71, 499-503 https://doi.org/10.1002/jmv.10506
  31. Peters, T.J., and Ward, R.J. (1988). Role of acetaldehyde in the pathogenesis of alcoholic liver disease. Mol. Aspects Med . 10, 179-190 https://doi.org/10.1016/0098-2997(88)90022-2
  32. Piao, Y.F., Li, J.T., and Shi, Y. (2003). Relationship between genetic polymorphism of cytochrome P450IIE1 and fatty liver. World J. Gastroenterol . 9, 2612-2615 https://doi.org/10.3748/wjg.v9.i11.2612
  33. Powell, H., Kitteringham, N.R., Pirmohamed, M., Smith, D.A., and Park, B.K. (1998). Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics 8, 411-421 https://doi.org/10.1097/00008571-199810000-00006
  34. Reicks, M.M., and Crankshaw, D.L. (1996). Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds. Nutr. Cancer 25, 241-248 https://doi.org/10.1080/01635589609514448
  35. Seitz, H.K., and Stickel, F. (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 7, 599-612 https://doi.org/10.1038/nrc2191
  36. Song, B.C., Cui, X.J., and Kim, H. (2005a). Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection. Intervirology 48, 133-137 https://doi.org/10.1159/000081740
  37. Song, B.C., Kim, H., Kim, S.H., Cha, C.Y., Kook, Y.H., and Kim, B.J. (2005b). Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J. Med. Virol. 75, 13-19 https://doi.org/10.1002/jmv.20230
  38. Stephens, M., Smith, N.J., and Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet . 68, 978-989 https://doi.org/10.1086/319501
  39. Stickel, F., and Osterreicher, C.H. (2006). The role of genetic polymorphisms in alcoholic liver disease. Alcohol Alcohol 41, 209-224 https://doi.org/10.1093/alcalc/agl011
  40. Stickel, F., Schuppan, D., Hahn, E.G., and Seitz, H.K. (2002). Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51, 132-139 https://doi.org/10.1136/gut.51.1.132
  41. Takahashi, T., Lasker, J.M., Rosman, A.S., and Lieber, C.S. (1993). Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 17, 236-245 https://doi.org/10.1002/hep.1840170213
  42. Tanaka, F., Shiratori, Y., Yokosuka, O., Imazeki, F., Tsukada, Y., and Omata, M. (1997). Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcohol Clin. Exp. Res . 21, 596-601 https://doi.org/10.1111/j.1530-0277.1997.tb03808.x
  43. Tsutsumi, M., Takada, A., and Wang, J.S. (1994). Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107, 1430-1435 https://doi.org/10.1016/0016-5085(94)90546-0
  44. Watanabe, J., Hayashi, S., and Kawajiri, K. (1994). Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region. J. Biochem . 116, 321-326 https://doi.org/10.1093/oxfordjournals.jbchem.a124526
  45. Yang, C.S., Smith, T.J., and Hong, J.Y. (1994). Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res . 54, 1982s-1986s
  46. Yoo, B.C., Park, J.W., Kim, H.J., Lee, D.H., Cha, Y.J., and Park, S.M. (2003). Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J. Hepatol . 38, 98-103
  47. Yu, M.W., Gladek-Yarborough, A., Chiamprasert, S., Santella, R.M., Liaw, Y.F., and Chen, C.J. (1995). Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109, 1266-1273 https://doi.org/10.1016/0016-5085(95)90587-1

Cited by

  1. Association Analysis of SERPINB5 Polymorphisms with HBV Clearance and HCC Occurrence in a Korean Population vol.8, pp.1, 2010, https://doi.org/10.5808/GI.2010.8.1.001
  2. Cytochrome P450 Genes (CYP2E1 and CYP1A1) Variants and Susceptibility to Chronic Hepatitis B Virus Infection pp.0974-0422, 2017, https://doi.org/10.1007/s12291-017-0698-6